Pande Atul bought IMVT
April 7, 2026 · Form 4 insider transaction
Pande Atul bought 7,061 shares of Immunovant, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,061
Price
$0.00
Total value
N/A
InsiderPande Atul
Role—
CompanyImmunovant, Inc. (IMVT)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 7, 2026
Filing dateApril 9, 2026
Shares owned after7,061
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.